$25.66
00.00%
Pre-Market: Jul 5, 4:02 PM EDT
15 minutes delayed
Anika Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Anika Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ANIK | Anika Therapeutics | $0.06 | $0.05 | — | — | $44.30M | $42.10M | — | — | 08/06/2024 | Get Alert |
ANIK | Anika Therapeutics | -$0.36 | -$0.19 | $0.09 | 147.37% | $37.92M | $39.14M | $40.52M | 3.53% | 05/08/2024 | Get Alert |
ANIK | Anika Therapeutics | -$0.21 | -$0.26 | $0.05 | 119.23% | $39.62M | $41.40M | $42.97M | 3.79% | 03/13/2024 | Get Alert |
ANIK | Anika Therapeutics | -$0.05 | -$0.37 | $0.00 | 100.00% | $40.26M | $38.27M | $41.47M | 8.35% | 11/02/2023 | Get Alert |
ANIK | Anika Therapeutics | -$0.12 | -$0.27 | $0.06 | 122.22% | $39.66M | $40.56M | $44.30M | 9.23% | 08/08/2023 | Get Alert |
ANIK | Anika Therapeutics | -$0.11 | -$0.30 | -$0.36 | -20.00% | $36.69M | $37.28M | $37.92M | 1.73% | 05/09/2023 | Get Alert |
ANIK | Anika Therapeutics | -$0.23 | -$0.24 | -$0.21 | 12.50% | $35.82M | $37.70M | $39.62M | 5.10% | 03/06/2023 | Get Alert |
ANIK | Anika Therapeutics | $0.05 | -$0.25 | -$0.05 | 80.00% | $39.54M | $37.59M | $40.26M | 7.11% | 11/08/2022 | Get Alert |
ANIK | Anika Therapeutics | $0.09 | -$0.23 | -$0.12 | 47.83% | $38.15M | $37.85M | $39.66M | 4.77% | 08/03/2022 | Get Alert |
ANIK | Anika Therapeutics | $0.06 | -$0.36 | -$0.11 | 69.44% | $34.29M | $32.90M | $36.69M | 11.53% | 05/05/2022 | Get Alert |
ANIK | Anika Therapeutics | $0.12 | -$0.25 | -$0.23 | 8.00% | $32.69M | $32.05M | $35.82M | 11.77% | 03/08/2022 | Get Alert |
ANIK | Anika Therapeutics | $0.05 | -$0.21 | $0.05 | 123.81% | $31.69M | $36.32M | $39.54M | 8.85% | 11/04/2021 | Get Alert |
ANIK | Anika Therapeutics | $0.09 | -$0.06 | $0.09 | 250.00% | $30.68M | $34.76M | $38.15M | 9.74% | 08/05/2021 | Get Alert |
ANIK | Anika Therapeutics | $0.45 | -$0.12 | $0.06 | 150.00% | $35.40M | $32.20M | $34.29M | 6.50% | 05/06/2021 | Get Alert |
ANIK | Anika Therapeutics | $0.43 | -$0.01 | $0.12 | 1300.00% | $29.77M | $33.50M | $32.69M | -2.42% | 03/04/2021 | Get Alert |
ANIK | Anika Therapeutics | $0.64 | -$0.01 | $0.05 | 600.00% | $29.70M | $30.11M | $31.69M | 5.26% | 11/04/2020 | Get Alert |
ANIK | Anika Therapeutics | $0.67 | -$0.24 | $0.09 | 137.50% | $30.42M | $20.37M | $30.68M | 50.60% | 07/30/2020 | Get Alert |
ANIK | Anika Therapeutics | $0.31 | — | $0.45 | — | $24.72M | $31.53M | $35.40M | 12.26% | 05/07/2020 | Get Alert |
ANIK | Anika Therapeutics | $0.54 | $0.42 | $0.43 | 2.38% | $26.96M | $27.57M | $29.77M | 7.99% | 02/20/2020 | Get Alert |
ANIK | Anika Therapeutics | $0.53 | $0.39 | $0.64 | 64.10% | $26.79M | $27.01M | $29.70M | — | 10/24/2019 | Get Alert |
ANIK | Anika Therapeutics | $0.68 | — | $0.67 | — | $30.55M | $27.50M | $30.42M | 10.61% | 07/24/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $0.09 | $-0.19 | 147.4 % |
Dec 2023 | 2024-03-13 | $0.05 | $-0.26 | 119.2 % |
Sep 2023 | 2023-11-02 | $0 | $-0.37 | 100.0 % |
Jun 2023 | 2023-08-08 | $0.06 | $-0.27 | 122.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $40.52M | $39.14M | 3.53 % |
Dec 2023 | 2024-03-13 | $42.97M | $41.40M | 3.79 % |
Sep 2023 | 2023-11-02 | $41.47M | $38.27M | 8.35 % |
Jun 2023 | 2023-08-08 | $44.30M | $40.56M | 9.23 % |
Anika Therapeutics (ANIK) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
The Actual EPS was $0.09, which beat the estimate of $-0.19.
The Actual Revenue was $40.5M, which beat the estimate of $39.1M.
Browse earnings estimates, EPS, and revenue on all stocks.